Chapter

Targeting Spinal and Bulbar Muscular Atrophy

From Share your story with the Oxford-Harrington Rare Disease Centre by öxford-Harrington RARE DISEASE CENTRE

Concepts

  1. Mutant Receptors

    "Professor Carlo Rinaldi, 2024 Oxford-Harrington Rare Disease Scholar, is developing a therapy to target mutant androgen receptors in spinal and bulbar muscular atrophy."

Targeting Spinal and Bulbar Muscular Atrophy | Share your story with the Oxford-Harrington Rare Disease Centre | Bifalgorithm | Bifalgorithm